Hunan Jiudian Pharmaceutical Co., Ltd. (SHE:300705)

China flag China · Delayed Price · Currency is CNY
12.83
-0.11 (-0.85%)
Apr 30, 2026, 11:05 AM CST
-19.61%
Market Cap 6.39B
Revenue (ttm) 3.01B
Net Income (ttm) 403.78M
Shares Out 494.11M
EPS (ttm) 0.81
PE Ratio 16.05
Forward PE 8.80
Dividend 0.40 (3.12%)
Ex-Dividend Date May 26, 2025
Volume 2,325,860
Average Volume 6,495,781
Open 13.62
Previous Close 12.94
Day's Range 12.80 - 13.62
52-Week Range 12.73 - 20.66
Beta 0.13
RSI 29.77
Earnings Date Apr 25, 2026

About SHE:300705

Hunan Jiudian Pharmaceutical Co., Ltd. researches, develops, produces, and sells pharmaceutical products in China and internationally. Its products portfolio includes Pantoprazole Sodium Enteric-coated, Ferrous Succinate, Rosuvastatin Calcium, Ebastine, and Rabeprazole Sodium Enteric-coated Tablets; and Acetylcysteine Granules, Potassium Sodium Hydrogen Citrate Granules, Loxoprofen Sodium Gel Patch, and Ketoprofen gel patch. The company also offers drugs for analgesic, cardio-cerebrovascular, anti-infection, digestive and urinary system, and br... [Read more]

Sector Healthcare
Founded 2001
Employees 2,221
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300705
Full Company Profile

Financial Performance

In 2025, SHE:300705's revenue was 3.11 billion, an increase of 6.15% compared to the previous year's 2.93 billion. Earnings were 472.82 million, a decrease of -7.72%.

Financial Statements

News

There is no news available yet.